InvestorsHub Logo
Followers 22
Posts 3688
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Monday, 11/02/2020 6:03:10 PM

Monday, November 02, 2020 6:03:10 PM

Post# of 8276
Revance to Release Third Quarter 2020 Financial Results on Monday, November 9, 2020

Conference Call Scheduled for Monday, November 9, 2020 at 4:30 p.m. ET

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, today announced that the company will release third quarter 2020 financial results on Monday, November 9, 2020 after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30 p.m. PT/4:30 p.m. ET on the same day to discuss the results and provide a business and pipeline update.

https://investors.revance.com/news-releases/news-release-details/revance-release-third-quarter-2020-financial-results-monday
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News